EPISODE · Oct 21, 2024 · 10 MIN
FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction
from JACC This Week
In this episode, Dr. David J. Schneider research identifies platelet FCγRIIA (PFCG) as a key biomarker for cardiovascular risk post-myocardial infarction. In an 800-patient study, higher PFCG levels were linked to increased risks of myocardial infarction, stroke, and death, indicating its potential for guiding personalized antiplatelet therapy, pending further validation.
Embed this episode
NOW PLAYING
FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction
0:00
10:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JACC This Week?
This episode is 10 minutes long.
When was this JACC This Week episode published?
This episode was published on October 21, 2024.
Can I download this JACC This Week episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!